Literature DB >> 30963007

Survival implications of transbronchial cryobiopsy and other diagnostic modalities in idiopathic pulmonary fibrosis.

Jasleen K Pannu1, Justin C Hewlett1, Aaron B Smith1,2,3,4, Wendi R Mason1, Heidi Chen3, Otis B Rickman1, Robert J Lentz1,4, Jonathan A Kropski1,4, Fabien Maldonado1.   

Abstract

Entities:  

Year:  2019        PMID: 30963007      PMCID: PMC6409248          DOI: 10.21037/jtd.2019.01.44

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN: 2072-1439            Impact factor:   2.895


× No keyword cloud information.
  9 in total

1.  In-Hospital Mortality after Surgical Lung Biopsy for Interstitial Lung Disease in the United States. 2000 to 2011.

Authors:  John P Hutchinson; Andrew W Fogarty; Tricia M McKeever; Richard B Hubbard
Journal:  Am J Respir Crit Care Med       Date:  2016-05-15       Impact factor: 21.405

2.  An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management.

Authors:  Ganesh Raghu; Harold R Collard; Jim J Egan; Fernando J Martinez; Juergen Behr; Kevin K Brown; Thomas V Colby; Jean-François Cordier; Kevin R Flaherty; Joseph A Lasky; David A Lynch; Jay H Ryu; Jeffrey J Swigris; Athol U Wells; Julio Ancochea; Demosthenes Bouros; Carlos Carvalho; Ulrich Costabel; Masahito Ebina; David M Hansell; Takeshi Johkoh; Dong Soon Kim; Talmadge E King; Yasuhiro Kondoh; Jeffrey Myers; Nestor L Müller; Andrew G Nicholson; Luca Richeldi; Moisés Selman; Rosalind F Dudden; Barbara S Griss; Shandra L Protzko; Holger J Schünemann
Journal:  Am J Respir Crit Care Med       Date:  2011-03-15       Impact factor: 21.405

Review 3.  Transbronchial cryobiopsy for diffuse parenchymal lung disease: a state-of-the-art review of procedural techniques, current evidence, and future challenges.

Authors:  Robert J Lentz; A Christine Argento; Thomas V Colby; Otis B Rickman; Fabien Maldonado
Journal:  J Thorac Dis       Date:  2017-07       Impact factor: 2.895

Review 4.  Clinical course and prediction of survival in idiopathic pulmonary fibrosis.

Authors:  Brett Ley; Harold R Collard; Talmadge E King
Journal:  Am J Respir Crit Care Med       Date:  2010-10-08       Impact factor: 21.405

5.  Radiological versus histological diagnosis in UIP and NSIP: survival implications.

Authors:  K R Flaherty; E L Thwaite; E A Kazerooni; B H Gross; G B Toews; T V Colby; W D Travis; J A Mumford; S Murray; A Flint; J P Lynch; F J Martinez
Journal:  Thorax       Date:  2003-02       Impact factor: 9.139

6.  A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis.

Authors:  Talmadge E King; Williamson Z Bradford; Socorro Castro-Bernardini; Elizabeth A Fagan; Ian Glaspole; Marilyn K Glassberg; Eduard Gorina; Peter M Hopkins; David Kardatzke; Lisa Lancaster; David J Lederer; Steven D Nathan; Carlos A Pereira; Steven A Sahn; Robert Sussman; Jeffrey J Swigris; Paul W Noble
Journal:  N Engl J Med       Date:  2014-05-18       Impact factor: 91.245

7.  Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis.

Authors:  Luca Richeldi; Roland M du Bois; Ganesh Raghu; Arata Azuma; Kevin K Brown; Ulrich Costabel; Vincent Cottin; Kevin R Flaherty; David M Hansell; Yoshikazu Inoue; Dong Soon Kim; Martin Kolb; Andrew G Nicholson; Paul W Noble; Moisés Selman; Hiroyuki Taniguchi; Michèle Brun; Florence Le Maulf; Mannaïg Girard; Susanne Stowasser; Rozsa Schlenker-Herceg; Bernd Disse; Harold R Collard
Journal:  N Engl J Med       Date:  2014-05-18       Impact factor: 91.245

8.  Morphometrical analysis of transbronchial cryobiopsies.

Authors:  Sergej Griff; Wim Ammenwerth; Nicolas Schönfeld; Torsten T Bauer; Thomas Mairinger; Torsten-Gerriet Blum; Jens Kollmeier; Wolfram Grüning
Journal:  Diagn Pathol       Date:  2011-06-16       Impact factor: 2.644

Review 9.  The current position of surgical lung biopsy in the diagnosis of idiopathic pulmonary fibrosis.

Authors:  Riitta Kaarteenaho
Journal:  Respir Res       Date:  2013-04-15
  9 in total
  1 in total

1.  Transbronchial lung cryobiopsy: prospective safety evaluation and 90-day mortality after a standardized examination protocol.

Authors:  Klaus Hackner; Antonia Stadler; Felix Schragel; Valerie Klamminger; Bahil Ghanim; Alexander Varga; Peter Errhalt
Journal:  Ther Adv Respir Dis       Date:  2022 Jan-Dec       Impact factor: 4.031

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.